A live webcast of the presentation will be available on the Investor section of Morphic’s website at www.morphictx.com. An archived replay will be available on the company’s website following the conference.
About Morphic Therapeutic
Morphic Therapeutic is a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis and cancer. In collaboration with AbbVie, Janssen, and Schrödinger,
Contacts
Morphic Therapeutic
chris.erdman@morphictx.com
617.686.1718
Media Contact
tom@tenbridgecommunications.com
857.559.3397
Source: Morphic Therapeutic
2022 GlobeNewswire, Inc., source